RVNC vs. ORLY
RVNC (Revance Therapeutics, Inc.) and ORLY (O'Reilly Automotive, Inc.) are both stocks. RVNC operates in Biotechnology (Healthcare), while ORLY operates in Specialty Retail (Consumer Cyclical).
Performance
RVNC vs. ORLY - Performance Comparison
Loading charts...
Returns By Period
RVNC
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ORLY
- 1D
- 1.33%
- 1M
- -7.02%
- YTD
- -4.20%
- 6M
- -11.39%
- 1Y
- -4.47%
- 3Y*
- 13.55%
- 5Y*
- 20.01%
- 10Y*
- 17.58%
RVNC vs. ORLY - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
RVNC Revance Therapeutics, Inc. | 0.00% |
ORLY O'Reilly Automotive, Inc. | -7.26% |
Fundamentals
RVNC:
$247.00M
ORLY:
$18.21B
RVNC:
$174.52M
ORLY:
$9.40B
RVNC:
-$150.16M
ORLY:
$3.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RVNC vs. ORLY — Risk / Return Rank
RVNC
ORLY
RVNC vs. ORLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Revance Therapeutics, Inc. (RVNC) and O'Reilly Automotive, Inc. (ORLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| RVNC | ORLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.20 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.89 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.67 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 0.64 | — |
Drawdowns
RVNC vs. ORLY - Drawdown Comparison
The maximum RVNC drawdown since its inception was 0.00%, smaller than the maximum ORLY drawdown of -65.42%. Use the drawdown chart below to compare losses from any high point for RVNC and ORLY.
Loading charts...
Drawdown Indicators
| RVNC | ORLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -65.42% | +65.42% |
Max Drawdown (1Y)Largest decline over 1 year | — | -20.02% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -20.02% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -23.03% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.00% | — |
Current DrawdownCurrent decline from peak | 0.00% | -18.96% | +18.96% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -10.78% | +10.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 10.41% | — |
Volatility
RVNC vs. ORLY - Volatility Comparison
Loading charts...
Volatility by Period
| RVNC | ORLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 6.51% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.05% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 22.87% | -22.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 22.60% | -22.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 26.51% | -26.51% |
Dividends
RVNC vs. ORLY - Dividend Comparison
Neither RVNC nor ORLY has paid dividends to shareholders.
Financials
RVNC vs. ORLY - Financials Comparison
This section allows you to compare key financial metrics between Revance Therapeutics, Inc. and O'Reilly Automotive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for RVNC and ORLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer